Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: Comparison with other hepatic cellular models

Journal of Hepatology

Volumn 31, Issue 3, 1999, Pages 542-549

  Donato, M Teresa ^a   Castell, José V ^a   Gómez Lechón, M José ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Bioartificial liver; Cytochrome P450; Drug metabolism; Interspecies differences; Liver microsomes; Pig hepatocytes; Primary cultures

Indexed keywords

CYTOCHROME P450; TESTOSTERONE;

ANIMAL CELL; ARTICLE; BIOREACTOR; BIOTRANSFORMATION; CELL METABOLISM; DEVICE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIVER CELL; LIVER METABOLISM; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SWINE;

EID: 0033199820     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80049-X     Document Type: Article

References (38)

1. Hughes RD, Williams R. Use of bioartificial and artificial liver support devices. Semin Liver Dis. 16:1996;435-444.
2. Flendrig LM, la Soe JW, Jorning GGA, Steenbeek A, Karlsen OT, Bovée WMMJ, et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol. 26:1997;1379-1392.
3. Guillouzo A, Morel F, Fardel O, Meunier B. Use of human heptocyte cultures for drug metabolism studies. Toxicology. 82:1993;209-219.
4. Gómez-Lechón MJ, Donato T, Ponsoda X, Fabra R, Trullenque R, Castell JV. Isolation, culture and use of human hepatocytes in drug research. Castell JV, Gómez-Lechón MJ, . In Vitro Methods in Pharmaceutical Research. 1997;129-153 Academic Press, London.
5. Sussman NJ, Kelly JH. Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs. 17:1993;27-30.
6. Rozga J, Williams F, Ro M.S., Neuzil DF, Giorgio TD, Backfisch G, et al. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology. 17:1993;258-265.
7. Koebe HG, Pahernik SA, Sproede M, Thasler WE, Schildberg F. Porcine hepatocytes from slaughterhouse organs. An unlimited resource for bioartificial liver devices. ASAIO J. 41:1995;189-193.
8. Donato MT, Bassi AM, Gómez-Lechón MJ, Penco S, Herrero E, Adamo D, et al. Evaluation of the xenobiotic biotransformation capability of six rodent hepatoma cell lines in comparison with rat hepatocytes. In Vitro Cell Dev Biol. 30A:1994;574-580.
9. Nyber SL, Shatford RA, Payne WD, Hu WS, Cerra FB. Primary culture of rat hepatocytes entrapped in cylindrical collagen gels: an in vitro system with application to the bioartificial liver. Cytotechnology. 10:1992;205-215.
10. Lazar A, Mann HJ, Remmel RP, Shatford RA, Cerra FB, Hu WS. Extended liver-specific functions of porcine hepatocyte spheroids entrapped in collagen gels. In Vitro Cell Dev Biol. 31:1993;340-346.
11. te Velde AA, Ladiges NCJJ, Flendring LM, Chamuleau RAFM. Functional activity of isolated pig hepatocytes attached to different extracellular matrix substrates. Implication for application of pig hepatocytes in a bioartificial liver. J Hepatol. 23:1995;184-192.
12. Naik S, Trenkler D, Santangini H, Pan J, Jauregui H. Isolation and culture of porcine hepatocytes for artificial liver support. Cell Transplant. 5:1993;107-115.
13. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. Ethoxy-, pentoxy-, and benzyloxyphenoxasones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol. 34:1995;3337-3345.
14. Sandhu P, Guo Z, Baba T, Martin MV, Tukey RH, Guengerich FP. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch. Biochem Biophys. 309:1994;168-177.
15. Nerurkar PV, Park SS, Thomas PE, Nims RW, Lubet RA. Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol. 46:1993;933-943.
16. Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ, Korzekwa K. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys. 290:1991;160-166.
17. Grimm SW, Dyroff MC, Philpot RM, Halpert JR. Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism. Mol Pharmacol. 46:1994;1090-1099.
18. Klekotka PA, Halpert JR. Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11). Drug Metab Dispos. 23:1995;1434-1435.
19. Yun C, Shimada T, Guengerich FP. Purification and characterizations of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol. 40:1991;679-685.
20. Ding X, Pernecky SJ, Coon MJ. Purification and characterization of cytochrome P450 2E2 from hepatic microsomes of neonatal rabbits. Arch Biochem Biophys. 291:1991;270-276.
21. Tassaneeyakul W, Veronese ME, Birkett DJ, Gonzalez FJ, Miners JO. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem Pharmacol. 46:1993;1975-1981.
22. Shiraga T, Iwasaki K, Nozaki K, Tamura T, Yamazoe Y, Kato R, et al. Isolation and characterization of four cytochrome P450 isozymes from untreated and phenobarbital-treated beagle dogs. Biol Pharm Bull. 17:1994;22-28.
23. Yamazaki H, Inoue K, Mimura M, Oda Y, Guengerich FP, Shimada T. 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes. Biochem Pharmacol. 51:1996;313-319.
24. Sonderfan AJ, Arlotto MP, Duttion DR, McMillen SK, Parkinson A. Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch Biochem Biophys. 255:1987;27-41.
25. Koop DR, Persson AV, Coon MJ. Properties of electrophoretically homogeneous constitutive forms of liver microsomal cytochrome P450. J Biol Chem. 256:1981;10701-10711.
26. Komori M, Hahizume T, Ohi H, Miura T, Kitada M, Nagashima K, et al. Cytochrome P-450 in human liver microsomes: highperformance liquid chromatographic isolation of three forms and their characterization. J Biochem. 104:1988;912-916.
27. Gómez-Lechón MJ, López MP, Castell JV. Biochemical functionality and recovery of hepatocytes after deep-freezing storage. In Vitro. 20:1984;826-832.
28. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
29. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. J Biol Chem. 239:1964;2370-2378.
30. Donato MT, Gómez-Lechón MJ, Castell JV. A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Anal Biochem. 213:1993;29-33.
31. Edwards AM, Glistak ML, Lucas CM, Wilson PA. 7-Ethoxycoumarin deethylase activity as a convenient measure of liver drug metabolizing enzymes: regulation in cultured rat hepatocytes. Biochem Pharmacol. 33:1984;1537-1546.
32. Donato MT, Castell JV, Gómez-Lechón MJ. Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. Drug Metab Dispos. 23:1995;553-558.
33. Castell JV, Gómez-Lechón MJ, Donato MT. Hepatocytes: in vitro pharmacology, toxicology and drug metabolism. metabolism studies. Spier RE, Griffiths JB, Berthold W, . Animal Cell Technology Products of Today, Prespects for Tomorrow. 1994;711-722 Butterworth-Heinemann Ltd, Oxford.
34. Rodrigues AD. Use of in vitro human metabolism studies in drug development. An industrial perspective. Biochem Pharmacol. 48:1994;2147-2156.
35. Witkamp RF, Nijmeijer SM, Monshouwer M, Van Miert ASJPAM. The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig. Drug Metab Dispos. 23:1995;542-547.
36. Nedelcheva V, Gut I. P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. Xenobiotica. 24:1994;1151-1175.
37. Eguchi K, Nishibe Y, Baba T, Ohno K. Quantitation of cytochrome P450 enzymes (CYP1A1/2, 2B11, 2C21 and 3A12) in dog liver microsomes by enzyme-linked immunosorbent assay. Xenobiotica. 26:1996;755-764.
38. Macé K, Offord EA, Pfeifer AMA. Drug metabolism and carcinogen activation studies with human genetically engineered cells. Castell JV, Gómez-Lechón MJ, . In Vitro Methods in Pharmaceutical Research. 1997;433-456 Academic Press, London.